Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
This is unchanged from the number of companies cited in the previous quarter.
The citations in the county include:
- You did not establish and maintain procedures for testing, screening and determining the eligibility of HCT/P donors.
- Equipment used in the compatibility testing and storage and distribution of blood and blood components is not calibrated on a regularly scheduled basis as prescribed in the SOP Manual.
- Written standard operating procedures including all steps to be followed in the compatibility testing and distribution of blood and blood components for allogeneic transfusion were not always established and followed.
Most of the companies cited were involved in the Biologics sector. The second most common type of company cited in the time period worked in the .
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Adequate control, proper conditions |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Use prior to verification |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Accurate, indelible, legible |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Records incomplete |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Records maintained concurrently |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Equipment observed, standardized, calibrated |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Establish, maintain and follow manufacturing SOPs |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Concurrent documentation |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Required records |
Pinnacle Fertility Labs New York | Biologics | 12/14/2023 | Testing, screening, donor eligibility procedures |
Ports America, Inc. | Food and Cosmetics | 10/10/2023 | Prevention of contamination |
Ports America, Inc. | Food and Cosmetics | 10/10/2023 | Signs for non-potable water |
TMRW Life Sciences, Inc. | Devices | 10/24/2023 | DHR - not or inadequately maintained |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Design changes - Lack of or Inadequate Procedures |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Design history file |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Lack of or inadequate receiving acceptance procedures |